You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for chlorthalidone; clonidine hydrochloride and what is the scope of freedom to operate?

Chlorthalidone; clonidine hydrochloride is the generic ingredient in three branded drugs marketed by Par Pharm, Natco Pharma, and Boehringer Ingelheim, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Summary for CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
US Patents:0
Tradenames:3
Applicants:3
NDAs:5
Clinical Trials: 2
DailyMed Link:CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto do CoracaoPhase 4
Conselho Nacional de Desenvolvimento Científico e TecnológicoPhase 4
VA Office of Research and Development

See all CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma CLORPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 071325-003 Feb 9, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim COMBIPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 017503-003 Apr 10, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma CLORPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 071325-001 Feb 9, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Par Pharm CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE chlorthalidone; clonidine hydrochloride TABLET;ORAL 071178-001 Dec 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim COMBIPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 017503-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim COMBIPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 017503-003 Apr 10, 1984 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim COMBIPRES chlorthalidone; clonidine hydrochloride TABLET;ORAL 017503-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.